MPWT
ATRS

MassMutual Private Wealth & Trust’s Antares Pharma, Inc. ATRS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-194
Closed -$1K – 1684
2021
Q4 		$1K Buy
+194
New +$678 ﹤0.01% 1371

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

MassMutual Private Wealth & Trust's ATRS Position: Q1 2022 in Review

MassMutual Private Wealth & Trust sold out of Antares Pharma, Inc. (ATRS) in Q1 2022, closing a stake of 194 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in ATRS in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 177 funds tracked by Wall St. Rank hold ATRS as of Q1 2022.

  • MassMutual Private Wealth & Trust reported no remaining Antares Pharma, Inc. position as of Q1 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 194 Antares Pharma, Inc. shares in Q1 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Antares Pharma, Inc. in Q4 2021 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Antares Pharma, Inc. position peaked at $1K in Q4 2021.
  • 177 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2022, filed 8 Apr 2022.